Journal
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
Volume 115, Issue 8, Pages 507-512Publisher
OXFORD UNIV PRESS
DOI: 10.1093/qjmed/hcz162
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81872478]
- Key Project of Applied Basic Research of Sichuan Science and Technology Department [2018JY0550]
Ask authors/readers for more resources
This review discusses the expression of PD-1/PD-L1 on B cells and their immunosuppressive role in solid tumors, aiming to explore the potential for diagnostic tools and new therapies involving this unique group of cells.
Expression of programmed cell death-1 (PD-1/CD279) on T cells and the ligand of PD-1, programmed death ligand-1 (PD-L1) (CD274/B7-H1) on tumor cells or other immune cells, such as myeloid-derived suppressor cells, are important mechanisms to induce malignant immunosuppression. PD-1/PD-L1 expression on B-cell subsets, as well as their signaling and inhibitory functions in solid tumors will be discussed in this review with the focus on how B cells expressing PD-1/PD-L1 play immunosuppressive roles in tumor progression, aiming to figure out the potential for development of diagnostic tools and new therapies involving this unique group of cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available